With Stake, Australia's leading investing platform, I'm excited to share the sixth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.
Clarity Pharmaceuticals is a clinical-stage cancer biotech company based in Australia. The company specializes in developing radiopharmaceutical products that can be used to image and diagnose various types of cancer. Clarity Pharmaceuticals is actively involved in extensive research, development, and clinical stage evaluation of its portfolio of novel radiopharmaceutical products. It was recently listed on the ASX in 2021 under the ticker CU6.
DISCLAIMER:
Views expressed are those of the individual only. This does not constitute financial advice.
You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.
Join the Facebook Group.
Follow Mark Bouris on Instagram, LinkedIn & YouTube.
See omnystudio.com/listener for privacy information.
Hosted on Acast. See acast.com/privacy for more information.
#377 The Future of MMA: Scaling, Technology, and Entrepreneurship
#376 Building a Fintech during 'Tech Wreck': Challenges, innovations, and managing shareholders
#375 Knowing When to Fold: Tips for walking away from business without regrets
#374 Kouk Bonus: When will inflation return to target?
#373 The wellness market is predicted to be worth $1.5 trillion: Life Cykel
#372 Bonus: Labor's crackdown on franking credits the start of dismantling franking system?
#371 The cost in being boring and why most businesses suck at this
#370 Struggling with financial stress? Advice from Melissa Caddick receivers liquidator
#369 L'Oréal Australia: Learn how a multinational company manages a crisis
#368 Kouk Bonus: Will we get another rate rise from the RBA this March?
#367 How to navigate rapid international expansion successfully: Ultra Violette
#366 Could Gen Zs expectations at work revolutionise business productivity?
#365 Should you consider scaling your business during an economic downturn?
#364 Moulding a 116-year-old business into a global experiential enterprise: Winning Group
#363 Kouk Bonus: What can we expect from the RBA in 2023?
#362 Save money, time and energy by adopting a growth marketing mindset: Insight Timer
#361 What should you do if someone is copying your product? Triangl co-founder Erin Deering
#360 Should you increase your spending during a financial down period? The Good Crisp Co.
#359 Powerful Steps: Building brand structure using your best asset – YOU
#358 Best of 2022: A countdown of your top 5
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
Hamish & Andy
The Howie Games
Motley Fool Money
Just the Gist
The Briefing